Trial Details

COMPLETED
Basic Information
Clinical ID c2430
Identifier NCT03495973
Trial Title Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn Disease
Interventions DRUG: Ustekinumab
Participant Information
Sponsor Janssen-Cilag Ltd.
City Örebro
Country/Region Sweden
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2017-10-25
Primary Completion Date 2020-11-22
Completion Date 2020-11-22